U.S. flag

An official website of the United States government

NM_007373.4(SHOC2):c.973-5del AND RASopathy

Germline classification:
Benign (2 submissions)
Last evaluated:
Jan 28, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000159104.6

Allele description [Variation Report for NM_007373.4(SHOC2):c.973-5del]

NM_007373.4(SHOC2):c.973-5del

Gene:
SHOC2:SHOC2 leucine rich repeat scaffold protein [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
10q25.2
Genomic location:
Preferred name:
NM_007373.4(SHOC2):c.973-5del
HGVS:
  • NC_000010.11:g.111004601del
  • NG_028922.1:g.90059del
  • NM_001269039.3:c.835-5del
  • NM_001324336.2:c.973-5del
  • NM_001324337.2:c.973-5del
  • NM_007373.4:c.973-5delMANE SELECT
  • LRG_753t1:c.973-5del
  • LRG_753:g.90059del
  • NC_000010.10:g.112764352del
  • NC_000010.10:g.112764359del
  • NM_007373.3:c.973-5del
  • NM_007373.3:c.973-5delT
Links:
dbSNP: rs730881016
NCBI 1000 Genomes Browser:
rs730881016
Molecular consequence:
  • NM_001269039.3:c.835-5del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001324336.2:c.973-5del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001324337.2:c.973-5del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_007373.4:c.973-5del - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
RASopathy
Synonyms:
rasopathies; Noonan spectrum disorder
Identifiers:
MONDO: MONDO:0021060; MedGen: C5555857

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000209047GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Benign
(Sep 23, 2014)
germlineclinical testing

Citation Link,

SCV002398101Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Jan 28, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From GeneDx, SCV000209047.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The variant is found in NOONAN panel(s).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV002398101.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024